End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.74 CNY | +2.11% | +4.36% | -17.21% |
04-26 | BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-01 | BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38% | MT |
Business Summary
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Comprehensive Solutions for Precision Medical Testing
32.4
%
| 2,504 | 35.5 % | 1,407 | 32.4 % | -43.79% |
Reproductive Health Basic Research and Clinical Application
27.1
%
| 1,116 | 15.8 % | 1,178 | 27.1 % | +5.55% |
Multi-omics Big Data Service and Synthetic
16.3
%
| 705 | 10.0 % | 707 | 16.3 % | +0.33% |
Cancer and Chronic Disease Prevention and Control and Translational Medicine
12.1
%
| 404 | 5.7 % | 525 | 12.1 % | +30.07% |
Infection Prevention and Control Basic Research and Clinical Application
11.9
%
| 2,301 | 32.7 % | 516 | 11.9 % | -77.59% |
Other
0.4
%
| 17 | 0.2 % | 17 | 0.4 % | +1.42% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China (Excluding Hong Kong, Macau and Taiwan)
79.5
%
| 3,622 | 51.4 % | 3,459 | 79.5 % | -4.50% |
Asia (Including Hong Kong, Macau and Taiwan) and Oceania
12.8
%
| 2,791 | 39.6 % | 558 | 12.8 % | -80.02% |
Europe and Africa
5.0
%
| 389 | 5.5 % | 217 | 5.0 % | -44.20% |
Americas
2.7
%
| 245 | 3.5 % | 116 | 2.7 % | -52.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Li Jian Zhao
CEO | Chief Executive Officer | - | 21-06-15 |
Jian Hua Wang
FOU | Founder | 70 | - |
Yu Jue Wang
DFI | Director of Finance/CFO | 46 | 21-06-15 |
Yu Tao Du
COO | Chief Operating Officer | 47 | 18-06-18 |
Ye Yin
BRD | Director/Board Member | 45 | - |
Li Ping Ao
IRC | Investor Relations Contact | - | - |
Qian Xu
SEC | Corporate Secretary | 40 | 15-06-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Hua Wang
FOU | Founder | 70 | - |
Hong Tao Wang
BRD | Director/Board Member | - | 16-03-28 |
Ye Yin
BRD | Director/Board Member | 45 | - |
- | - | ||
Yu Jie Hu
BRD | Director/Board Member | 40 | 15-06-21 |
Yu Tao Du
COO | Chief Operating Officer | 47 | 18-06-18 |
Lan Du
BRD | Director/Board Member | 48 | 21-08-12 |
Si Qi Liu
CHM | Chairman | 71 | 21-06-15 |
Ya Cao
BRD | Director/Board Member | 73 | 21-06-15 |
Li Jian Zhao
CEO | Chief Executive Officer | - | 21-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 417,914,466 | 215,943,776 ( 51.67 %) | 4,000,141 ( 0.9572 %) | 51.67 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BANGKOK GENOMICS INNOVATION 37.40% | 224,400,000 | 37.40% | 20,786,172 $ |
1,065,173 | 1.28% | 4,086,813 $ |
Company contact information
BGI Genomics Co., Ltd.
7/F, North Building, Xinhuadu Bldg 162 Wusi Road
350003, Fuzhou
+
http://www.genomics.cnSector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.21% | 2.08B | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 377M | |
+13.32% | 332M |
- Stock Market
- Equities
- 300676 Stock
- Company BGI Genomics Co., Ltd.